CAAS Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-115,829
Closed -$19.8M 1033
2021
Q1
$19.8M Buy
+115,829
New +$19.8M 0.21% 40
2020
Q3
Sell
-257,928
Closed -$29.4M 442
2020
Q2
$29.4M Buy
+257,928
New +$29.4M 0.97% 21